Effect of Inflow of Fresh Blood on Vascular-Space-Occupancy (VASO) Contrast

被引:22
|
作者
Donahue, Manus J. [1 ,2 ,3 ]
Hua, Jun [1 ,2 ,4 ]
Pekar, James J. [1 ,2 ]
van Zijl, Peter C. M. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div MR Res, Baltimore, MD 21205 USA
[2] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA
[3] Univ Oxford, Dept Clin Neurol, Oxford Ctr Funct MRI Brain, Oxford OX1 2JD, England
[4] Johns Hopkins Univ, Sch Med, Dept Elect & Comp Engn, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
VASO; CBV; fresh blood; inflow; exchange; 3.0; TESLA; FLOW; OXYGENATION; VOLUME; MRI; BOLD; FMRI; T-1;
D O I
10.1002/mrm.21804
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In vascular-space-occupancy (VASO)-MRI,cerebral blood volume (CBV)-weighted contrast Is generated by applying a nonselective inversion pulse followed by imaging when blood water magnetization is zero. An uncertainty in VASO relates to the completeness of blood water nulling. Specifically, radio frequency (RF) coils produce a finite inversion volume, rendering the possibility of fresh, non-nulled blood. Here, VASO-functional MRI (fMRI) was performed for varying inversion volume and TR using body coil RF transmission. For thin inversion volume thickness (delta(tot) < 10 mm), VASO signal changes were positive (Delta S/S = 2.1-2.6%). Signal changes were negative and varied in magnitude for intermediate inversion volumes (delta(tot) = 100-300 mm), yet did not differ significantly (P > 0.05) for delta(tot) > 300 mm. These data suggest that blood water Is in steady state for delta(tot) > 300 mm. In this appropriate range, long-TR VASO data converged to a less negative value (Delta S/S = -1.4% +/- 0.2%) than short-TR data (Delta S/S = -2.2% +/- 0.2%), implying that cerebral blood flow or transit-state effects may Influence VASO contrast at short TR. Magn Reson Med 61:473-480,2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:473 / 480
页数:8
相关论文
共 36 条
  • [31] Detecting resting-state brain activity by spontaneous cerebral blood volume fluctuations using whole brain vascular space occupancy imaging
    Miao, Xinyuan
    Gu, Hong
    Yan, Lirong
    Lu, Hanzhang
    Wang, Danny J. J.
    Zhou, Xiaohong Joe
    Zhuo, Yan
    Yang, Yihong
    NEUROIMAGE, 2014, 84 : 575 - 584
  • [32] Contrast-enhanced blood-pool MR angiography with optimized iron oxides: Effect of size and dose on vascular contrast enhancement in rabbits
    Allkemper, T
    Bremer, C
    Matuszewski, L
    Ebert, W
    Reimer, P
    RADIOLOGY, 2002, 223 (02) : 432 - 438
  • [33] Editorial for "Noninvasive Assessment of MGMT Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space Occupancy Combined with Structural MR Imaging"
    Politi, Letterio S.
    Pessina, Federico
    Simonelli, Matteo
    Navarria, Pierina
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 54 (01) : 237 - 238
  • [34] The Effect of Blood Inflow and B1-Field Inhomogeneity on Measurement of the Arterial Input Function in Axial 3D Spoiled Gradient Echo Dynamic Contrast-Enhanced MRI
    Roberts, Caleb
    Little, Ross
    Watson, Yvonne
    Zhao, Sha
    Buckley, David L.
    Parker, Geoff J. M.
    MAGNETIC RESONANCE IN MEDICINE, 2011, 65 (01) : 108 - 119
  • [35] The effect of AMG 706, a novel multi-kinase inhibitor, on vascular permeability and blood flow as assessed by dynamic contrast enhanced magnetic resonance imaging in an in vivo preclinical tumor model
    Jackson, E
    Esparza-Coss, E
    Bankson, JA
    Coxon, A
    Patel, V
    Polverino, T
    Radinsky, R
    Starnes, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 225S - 225S
  • [36] The effect of AMG 706, a novel tyrosine kinase inhibitor, on vascular permeability and blood flow as assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in an in vivo preclinical tumor model.
    Jackson, EF
    Esparza-Coss, E
    Bankson, A
    Coxon, A
    Patel, V
    Kendall, R
    Pclverino, T
    Radinsky, R
    Starnes, C
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9037S - 9037S